Moderna closed at 188.94 USD, down 1.89%.

A cross-expiration call spread package with a net credit of $555.60 thousand was the standout large trade, leaning bearish to neutral. The trader sold the 197.50 calls and bought the 207.50 calls on the 2026-10-09 expiration, forming a bear call spread above the current stock price, while also buying the 210.00 calls and selling the 220.00 calls on the 2026-10-02 expiration. Overall, the bulk flow suggests institutional positioning for capped upside and a mildly negative directional bias.

>>>Start OPTIONS trading & earn up to SGD 200 in rewards!

Options Indicators

Moderna currently has an implied volatility of 90.08%, and with an IV percentile of 81.27%, its volatility is in an elevated range, indicating that options are priced expensively relative to their own recent history. The IV/HV ratio of 1.29 further suggests implied volatility is running above realized volatility, meaning the options market is embedding a relatively rich premium for expected future movement. The Call/Put volume ratio is 1.65.

Large Trades

A cross-expiration call spread package with a net credit of $555.60 thousand was the standout large trade, and it leans bearish to neutral in structure. On the 2026-10-09 expiration, the trader sold the 197.50 calls and bought the 207.50 calls, forming a bear call spread above the current stock price of 188.94, with both strikes out of the money; that points to a premium-collection view that Moderna is unlikely to rally aggressively beyond 197.50 into that tenor. On the 2026-10-02 expiration, the trader bought the 210.00 calls and sold the 220.00 calls, creating a smaller bull call spread that is also fully out of the money, suggesting a limited upside hedge or tactical near-term upside flyer rather than a high-conviction bullish bet. Taken together, this is best read as a calendarized call-spread combination executed for net credit, with the trader monetizing richer upside premium in the later expiry while retaining a narrowly defined shorter-dated upside exposure.

Overall, the large-trade flow in Moderna tilts bearish. The dominant block was structured to collect premium from upside call sales in the longer-dated tenor, while the added short-dated long call spread only modestly offsets that stance and appears more like risk management than outright bullish positioning. In short, the bulk order profile suggests the market is not expecting a major sustained upside breakout and is instead positioning for capped or subdued price action with a mildly negative directional bias.

Strategy Reference

For sellers seeking low assignment probability after elevated IV, the 220.00 call on the 2026-10-02 expiration could be a candidate given its fully out-of-the-money status and rich premium; alternatively, a defined-risk bear call spread like the sold 197.50/bought 207.50 package on 2026-10-09 limits margin while collecting net credit.